Sitagliptin/Simvastatin
Background The purpose of this study was to review the current literature and information on the combination product Juvisync™ (sitagliptin + simvastatin), which was approved by the US Food and Drug Administration in October 2011. Methods PubMed (2001–2014) was searched for primary and review articl...
Saved in:
| Main Author: | Ramadan, Wijdan H. (author) |
|---|---|
| Other Authors: | Kabbara, Wissam K. (author) |
| Format: | article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/10725/4485 http://dx.doi.org/ 10.2147/VHRM.S79198 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334171/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of cracked tooth using simvastatin as intracanal medicament
by: Mohamed Fawzy (10724622)
Published: (2020) -
Trends of acetaminophen overuse among ambulatory patients in Lebanon
by: Ramadan, Wijdan H.
Published: (2016) -
Prescription patterns of benzodiazepines in the Lebanese adult population
by: Ramadan, Wijdan H.
Published: (2016) -
Olodaterol for the treatment of chronic obstructive pulmonary disease
by: Ramadan, Wijdan H.
Published: (2016) -
Enzalutamide for patients with metastatic castration-resistant prostate cancer
by: Ramadan, Wijdan H.
Published: (2015)